DK2869841T3 - Hidtil ukendte prime-boosting-regimer, der omfatter immunogene polypeptider kodet af polynukleotider - Google Patents
Hidtil ukendte prime-boosting-regimer, der omfatter immunogene polypeptider kodet af polynukleotider Download PDFInfo
- Publication number
- DK2869841T3 DK2869841T3 DK13734111.1T DK13734111T DK2869841T3 DK 2869841 T3 DK2869841 T3 DK 2869841T3 DK 13734111 T DK13734111 T DK 13734111T DK 2869841 T3 DK2869841 T3 DK 2869841T3
- Authority
- DK
- Denmark
- Prior art keywords
- polynucleotides
- polypeptides encoded
- immunogenic polypeptides
- boosting regimens
- novel prime
- Prior art date
Links
- 230000002163 immunogen Effects 0.000 title 1
- 102000040430 polynucleotide Human genes 0.000 title 1
- 108091033319 polynucleotide Proteins 0.000 title 1
- 239000002157 polynucleotide Substances 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/235—Adenoviridae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/275—Poxviridae, e.g. avipoxvirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2012/063196 WO2014005643A1 (en) | 2012-07-05 | 2012-07-05 | Novel prime-boosting regimens involving immunogenic polypeptides encoded by polynucleotides |
| PCT/EP2013/064286 WO2014006191A1 (en) | 2012-07-05 | 2013-07-05 | Novel prime-boosting regimens involving immunogenic polypeptides encoded by polynucleotides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2869841T3 true DK2869841T3 (da) | 2021-10-25 |
Family
ID=48746554
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK13734111.1T DK2869841T3 (da) | 2012-07-05 | 2013-07-05 | Hidtil ukendte prime-boosting-regimer, der omfatter immunogene polypeptider kodet af polynukleotider |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US20150209420A1 (enExample) |
| JP (1) | JP6244358B2 (enExample) |
| KR (1) | KR20150038010A (enExample) |
| CN (1) | CN104780937A (enExample) |
| AU (1) | AU2013285398A1 (enExample) |
| BR (1) | BR112014033077A2 (enExample) |
| CA (1) | CA2878367A1 (enExample) |
| DK (1) | DK2869841T3 (enExample) |
| EA (1) | EA201492230A1 (enExample) |
| ES (1) | ES2895070T3 (enExample) |
| HU (1) | HUE056675T2 (enExample) |
| IL (1) | IL236414A0 (enExample) |
| IN (1) | IN2014KN03063A (enExample) |
| LT (1) | LT2869841T (enExample) |
| MX (1) | MX365391B (enExample) |
| PT (1) | PT2869841T (enExample) |
| SG (1) | SG11201408746XA (enExample) |
| WO (2) | WO2014005643A1 (enExample) |
| ZA (1) | ZA201500102B (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2988780T1 (sl) | 2013-04-25 | 2019-05-31 | Janssen Vaccines & Prevention B.V. | Stabilizirani topni prefuzijski RSV F polipeptidi |
| MX384992B (es) * | 2014-06-13 | 2025-03-14 | Glaxosmithkline Biologicals Sa | Combinaciones inmunógenas. |
| JP6462861B2 (ja) | 2014-09-03 | 2019-01-30 | バヴァリアン ノルディック エー／エス | フィロウイルス感染に対する防御免疫の誘導を目的とする方法及び組成物 |
| KR20190062617A (ko) | 2014-09-03 | 2019-06-05 | 버베리안 노딕 에이/에스 | 면역 반응을 증대시키기 위한 방법 및 조성물 |
| US9630994B2 (en) | 2014-11-03 | 2017-04-25 | University Of Washington | Polypeptides for use in self-assembling protein nanostructures |
| RU2742993C2 (ru) | 2015-05-15 | 2021-02-12 | Куревак Аг | РЕЖИМЫ ПРАЙМ-БУСТ, ВКЛЮЧАЮЩИЕ ВВЕДЕНИЕ ПО МЕНЬШЕЙ МЕРЕ ОДНОЙ КОНСТРУКЦИИ мРНК |
| DK3319633T3 (da) | 2015-07-07 | 2021-02-01 | Janssen Vaccines & Prevention Bv | Vaccine mod rsv |
| EP3319634B1 (en) | 2015-07-07 | 2019-08-21 | Janssen Vaccines & Prevention B.V. | Stabilized soluble pre-fusion rsv f polypeptides |
| MA43763B1 (fr) | 2016-04-05 | 2021-03-31 | Janssen Vaccines & Prevention Bv | Protéine f de pré-fusion du vrs soluble et stabilisée pour son utilisation dans la prophylaxie d'une infection vrs |
| MX2018012095A (es) | 2016-04-05 | 2019-01-10 | Janssen Vaccines & Prevention Bv | Vacuna contra vrs. |
| EP3452087A1 (en) * | 2016-05-02 | 2019-03-13 | Janssen Vaccines & Prevention B.V. | Therapeutic hpv vaccine combinations |
| JP2019523644A (ja) | 2016-05-30 | 2019-08-29 | ヤンセン ファッシンズ アンド プリベンション ベーフェーＪａｎｓｓｅｎ Ｖａｃｃｉｎｅｓ ＆ Ｐｒｅｖｅｎｔｉｏｎ Ｂ．Ｖ． | 安定化された融合前ｒｓｖ ｆタンパク質 |
| US10925956B2 (en) | 2016-07-15 | 2021-02-23 | Janssen Vaccines & Prevention B.V. | Methods and compositions for inducing protective immunity against a marburg virus infection |
| ES3040563T3 (en) | 2017-04-04 | 2025-11-03 | Univ Washington | Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus f proteins and their use |
| US11173204B2 (en) | 2017-04-06 | 2021-11-16 | Janssen Vaccines & Prevention B.V. | MVA-BN and Ad26.ZEBOV or Ad26.filo prime-boost regimen |
| JP2020519663A (ja) | 2017-05-17 | 2020-07-02 | ヤンセン ファッシンズ アンド プリベンション ベーフェーＪａｎｓｓｅｎ Ｖａｃｃｉｎｅｓ ＆ Ｐｒｅｖｅｎｔｉｏｎ Ｂ．Ｖ． | Ｒｓｖ感染に対する防御免疫を誘導するための方法及び組成物 |
| WO2018210871A1 (en) * | 2017-05-17 | 2018-11-22 | Janssen Vaccines & Prevention B.V. | Methods and compositions for inducing protective immunity against rsv infection |
| US11229695B2 (en) | 2017-09-15 | 2022-01-25 | Janssen Vaccines & Prevention B.V. | Method for the safe induction of immunity against RSV |
| EP3700560A1 (en) * | 2017-10-25 | 2020-09-02 | Nouscom AG | Eukaryotic cell line |
| EP3706770A4 (en) * | 2017-11-07 | 2021-10-27 | Nektar Therapeutics | IMMUNOTHERAPEUTIC COMBINATION FOR THE TREATMENT OF CANCER |
| CN112088014A (zh) | 2018-02-28 | 2020-12-15 | 华盛顿大学 | 自组装纳米结构疫苗 |
| CR20210306A (es) | 2018-11-13 | 2021-07-22 | Janssen Vaccines & Prevention Bv | Proteínas f de prefusión del vrs estabilizadas |
| GB201910794D0 (en) * | 2019-07-29 | 2019-09-11 | Pirbright Inst | Vaccine |
| CN112220921B (zh) * | 2020-08-25 | 2022-08-16 | 北京交通大学 | 一种针对呼吸道合胞病毒感染的组合疫苗 |
| CN117304280B (zh) * | 2023-11-28 | 2024-04-16 | 江苏瑞科生物技术股份有限公司 | 一种重组rsv f蛋白及其应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6511845B1 (en) * | 1992-08-07 | 2003-01-28 | Alan R. Davis | Methods for producing an immune response against HIV-1 |
| US6180398B1 (en) * | 1996-07-12 | 2001-01-30 | Virogeneitics Corporation | Two-step immunization procedure against the pyramyxoviridae family of viruses using recombinant virus and subunit protein preparation |
| GB9711957D0 (en) * | 1997-06-09 | 1997-08-06 | Isis Innovation | Methods and reagents for vaccination |
| WO2005017149A1 (en) * | 2003-06-03 | 2005-02-24 | Cell Genesys, Inc. | Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| ES2337374T3 (es) | 2004-01-23 | 2010-04-23 | Istituto Di Richerche Di Biologia Molecolare P. Angeletti S.P.A. | Portadores de vacunas de adenovirus de chimpance. |
| EP2001516A4 (en) * | 2006-03-10 | 2010-04-28 | Univ California | VACCINATES AGAINST PERSISTENT OR LATENT INFECTIONS THREADING VIRUSES |
| US20070292922A1 (en) * | 2006-03-31 | 2007-12-20 | Cell Genesys, Inc. | Regulated expression of recombinant proteins from adeno-associated viral vectors |
| EP2104681A4 (en) * | 2007-01-05 | 2011-01-19 | Inseron Inc | OPTIMIZED GREEN FLUORESCENT PROTEIN FOR EXPRESSION OF SELF-COLDING POLYPEPTIDES |
| GB0706914D0 (en) * | 2007-04-10 | 2007-05-16 | Isis Innovation | Novel adenovirus vectors |
| US20090092635A1 (en) * | 2007-08-17 | 2009-04-09 | Wyeth | Heterologous prime-boost immunization regimen |
| CL2007002710A1 (es) * | 2007-09-20 | 2008-01-04 | Univ Pontificia Catolica Chile | Formulacion inmunogenica que confiere proteccion contra la infeccion o patologia causada por el virus respiratorio sincicial (vrs) que comprende una cepa recombinante atenuada de mycobacterium; y uso de la formulacion inmunogenica para preparar una vacuna para prevenir, tratar o atenuar infecciones del vrs. |
| US7863425B2 (en) * | 2007-09-26 | 2011-01-04 | Cornell University | Compositions and methods for inhibiting Yersinia pestis infection |
| GB0823497D0 (en) * | 2008-12-24 | 2009-01-28 | Isis Innovation | Immunogenic composition and use thereof |
| MX2011007980A (es) * | 2009-02-02 | 2011-08-17 | Okairos Ag | Secuencias de acido nucleico y aminoacido de adenovirus de simio, vectores que contienen los mismos y usos de las mismas. |
| CN102740880A (zh) * | 2009-05-18 | 2012-10-17 | 万能药生物有限公司 | 基于重组修饰的安卡拉痘苗（mva）病毒的通用流感疫苗 |
| US9095546B2 (en) * | 2009-07-20 | 2015-08-04 | National Health Research Institutes | Human respiratory syncytial virus (RSV) vaccine |
| WO2012021730A2 (en) | 2010-08-11 | 2012-02-16 | Genvec, Inc. | Respiratory syncytial virus (rsv) vaccine |
| WO2012085936A2 (en) * | 2010-12-20 | 2012-06-28 | Panacea Biotech Ltd | Recombinant respiratory syncytial virus plasmids and vaccines |
| US9119813B2 (en) * | 2012-03-22 | 2015-09-01 | Crucell Holland B.V. | Vaccine against RSV |
-
2012
- 2012-07-05 WO PCT/EP2012/063196 patent/WO2014005643A1/en not_active Ceased
-
2013
- 2013-07-05 JP JP2015519233A patent/JP6244358B2/ja not_active Expired - Fee Related
- 2013-07-05 PT PT137341111T patent/PT2869841T/pt unknown
- 2013-07-05 IN IN3063KON2014 patent/IN2014KN03063A/en unknown
- 2013-07-05 US US14/408,340 patent/US20150209420A1/en not_active Abandoned
- 2013-07-05 DK DK13734111.1T patent/DK2869841T3/da active
- 2013-07-05 HU HUE13734111A patent/HUE056675T2/hu unknown
- 2013-07-05 BR BR112014033077A patent/BR112014033077A2/pt not_active Application Discontinuation
- 2013-07-05 CA CA2878367A patent/CA2878367A1/en active Pending
- 2013-07-05 KR KR20157003211A patent/KR20150038010A/ko not_active Withdrawn
- 2013-07-05 ES ES13734111T patent/ES2895070T3/es active Active
- 2013-07-05 EA EA201492230A patent/EA201492230A1/ru unknown
- 2013-07-05 MX MX2014016119A patent/MX365391B/es active IP Right Grant
- 2013-07-05 AU AU2013285398A patent/AU2013285398A1/en not_active Abandoned
- 2013-07-05 LT LTEPPCT/EP2013/064286T patent/LT2869841T/lt unknown
- 2013-07-05 WO PCT/EP2013/064286 patent/WO2014006191A1/en not_active Ceased
- 2013-07-05 SG SG11201408746XA patent/SG11201408746XA/en unknown
- 2013-07-05 CN CN201380044981.3A patent/CN104780937A/zh active Pending
-
2014
- 2014-12-23 IL IL236414A patent/IL236414A0/en unknown
-
2015
- 2015-01-07 ZA ZA2015/00102A patent/ZA201500102B/en unknown
-
2017
- 2017-11-01 US US15/800,245 patent/US20180256704A1/en not_active Abandoned
-
2023
- 2023-02-28 US US18/115,556 patent/US20240091338A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IL236414A0 (en) | 2015-02-26 |
| PT2869841T (pt) | 2021-10-28 |
| JP2015526403A (ja) | 2015-09-10 |
| SG11201408746XA (en) | 2015-01-29 |
| ZA201500102B (en) | 2017-09-27 |
| CN104780937A (zh) | 2015-07-15 |
| US20150209420A1 (en) | 2015-07-30 |
| LT2869841T (lt) | 2021-11-25 |
| MX2014016119A (es) | 2015-09-23 |
| HUE056675T2 (hu) | 2022-02-28 |
| IN2014KN03063A (enExample) | 2015-05-08 |
| US20180256704A1 (en) | 2018-09-13 |
| AU2013285398A1 (en) | 2015-02-05 |
| MX365391B (es) | 2019-05-31 |
| ES2895070T3 (es) | 2022-02-17 |
| US20240091338A1 (en) | 2024-03-21 |
| JP6244358B2 (ja) | 2017-12-06 |
| KR20150038010A (ko) | 2015-04-08 |
| WO2014006191A1 (en) | 2014-01-09 |
| EA201492230A1 (ru) | 2015-06-30 |
| BR112014033077A2 (pt) | 2017-08-01 |
| WO2014005643A1 (en) | 2014-01-09 |
| CA2878367A1 (en) | 2014-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2869841T3 (da) | Hidtil ukendte prime-boosting-regimer, der omfatter immunogene polypeptider kodet af polynukleotider | |
| HUS1700030I1 (hu) | Véralvadásgátló-antidótumok | |
| BR112015005783A2 (pt) | análogos de glucagon. | |
| LT3473714T (lt) | Polipeptidai, pasižymintys transgalaktozilinimo aktyvumu | |
| DK2822575T3 (da) | Manipulerede, muterede antistof-interferon-fusionsmolekyler | |
| DK2931551T3 (da) | Styring af rækkeviddeudvider | |
| DK2831510T3 (da) | Varmepumpesystem, der anvender latent varme | |
| DK2571903T3 (da) | Polymerer, der reagerer på stimuli, til oprensning af biomolekyler | |
| EP2934454C0 (en) | Anti-dandruff composition | |
| PT2928489T (pt) | Composição imunogénica | |
| EP2838100A4 (en) | Switch | |
| DK2867230T3 (da) | Fremgangsmåde til fremstilling af 3,5-disubstitueret 1,2,4-oxadiazoler | |
| GB2503742B (en) | Collapsible ladder | |
| EP2888965A4 (en) | KIMONO | |
| EP2840672A4 (en) | SWITCHING | |
| DK3524230T3 (da) | Farmakologiske formuleringer, der omfatter ccr3-antagonister | |
| EP2878633A4 (en) | curing composition | |
| SI2828926T1 (sl) | Nadzorni svetilnik | |
| EP2838952A4 (en) | Fluoropolymer COMPOSITION | |
| FR2986872B1 (fr) | . | |
| FR2991627B1 (fr) | Document de securite a haute durabilite | |
| ITTO20130048A1 (it) | Motociclo. | |
| EP2878639A4 (en) | Hardening composition | |
| FR2997489B1 (fr) | Artillerie pivotante | |
| CU24181B1 (es) | POLIPÉPTIDOS DERIVADOS DEL TGFß |